(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

JAMP PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

JAMP PHARMA

ST13

US500000079390054

Class

5, 35

Filing

79390054

Registration

7583174

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

04/03/2026

Classification

Registered

Trademark type

Combined

Nice classes

5, 35

Filing date

09/27/2023

Registration date

12/03/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/03/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

CA

Examiner

HARMON, RAYMOND E

Law office

L30

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of a circular design interrupted by a curved opening near the bottom-center of the design, to the left of the stylized wording "JAMP PHARMA".

Holders and representatives

Holders

J. C. (pessoa física)

Representatives

Brent E.. Routman Merchant & Gould, P.C.

Technical classification

Nice Classes

Class 5Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsprescription and non-prescription pharmaceutical preparations and drugs for the treatment of respiratory system diseases and disorderscardiovascular diseasescentral nervous system diseases and disordersbrain diseasesspinal cord diseases and injuriesmovement and seizure disordersgenitourinary diseases and disorderspelvic diseasesurological diseases and sexually transmitted diseasesgynecological diseases and disordersgastrointestinal diseases and disordersmusculoskeletal system diseases and disordersconnective tissue diseasesbone diseasesback painfracturessprainscartilage injuriesendocrine and metabolic diseases and disordershyperlipidemiahypercalcemiadiabetesgoutanemiacholestatic liver diseasesprimary biliary cirrhosis (PBC)skin diseases and disordersdermatitis and fungal diseasesocular diseases and disordersallergiescoldcoughsinus diseases and disordershypertensionsexual diseases and disordersprostate diseases and disorderscancerobesityinflammation and inflammatory diseases and disordersinflammatory bowel diseasesinflammatory connective tissue diseasesinfectious diseases and disordersrespiratory infectionseye infectionstopical infectionsimmunological diseasesautoimmune diseasesimmunologic deficiency syndromeviral diseases and disordersherpeshepatitisacquired immune deficiency syndrome (aids)parasitic diseasesmalariaparasitic infectionsintestinal wormspsychiatric diseases and disordersmood disordersanxiety disorderscognitive disordersschizophrenia and bipolar disordersdental and oral diseasesmouth diseasesesophageal diseases and toothachesmotion sicknesscarpal tunnel syndrome and painheadachesmigrainesback painpain from burnsneuropathic painchronic pain associated with osteoarthritis of the kneetransplant rejectionhyperfibrinolysishereditary angioedemadrug abuse and biosimilar biologic drugs for the treatment of inflammatory diseases and disordersinflammatory connective tissue diseases and inflammatory bowel diseasesskin diseases and disorderspsoriasis and hidradenitis suppurativaocular diseases and disordersinflammation of the uvea or uveal tract; natural health product preparationsdietary supplementsnutritional supplements and herbal supplements for general health and well-beingfood supplements containing natural plant extractsnatural algaenatural algae extracts and fungus extractsvitaminsmineral supplementsamino acidsfatty acidsdietary fibreprobiotics dietary supplementsenzyme and protein supplements in powdercapsuletablet and liquid formall for maintaining brain healthfor neuroprotectionfor improving or preserving cognitionmemory and brain function; vitamins and nutritional supplementsvitamins and nutritional supplements in the form of calciumelectrolyte drinksenergy barsenergy drinksjuice drinkslecithinmineralsvitamins for pharmaceuticalmedicinal and therapeutic use

Class 35

Business management with relation to strategymarketingproductionpersonnel and retail sale matters of pharmaceutical preparationsdrugs and biosimilar biologic drugs for promoting optimal health of the human bodyprescription and non-prescription pharmaceutical preparationsvitamins and nutritional supplements

Publications

History of USPTO decisions and trademark events.

18 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/03/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/03/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/01/2024

PUBO

PUBLISHED FOR OPPOSITION

10/01/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/11/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/23/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/23/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/23/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/23/2024

RFNT

REFUSAL PROCESSED BY IB

07/15/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/24/2024

RFRR

REFUSAL PROCESSED BY MPU

06/24/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/14/2024

CNRT

NON-FINAL ACTION WRITTEN

06/03/2024

DOCK

ASSIGNED TO EXAMINER

05/18/2024

MAFR

APPLICATION FILING RECEIPT MAILED

02/27/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/23/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/22/2024

Continuous trademark protection

Get notified about every new filing that threatens JAMP PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.